Besides the concervative valuation...one of the most interesting parts is:"As the Company continues to de-risk the project, we expect to see significant share price appreciation" ...That says it all for me....
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil
